Brainreader
PrivateLast Round
Series A
May 28, 2025
Total Funding Raised
$10.24M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Brainreader is a healthtech company that develops and provides Neuroreader®, an FDA-cleared and CE-marked software that uses AI for volumetric analysis of brain MRI scans to assist in the diagnosis of neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Brainreader Comparables
Compare Brainreader with similar companies based on industry and business-model similarity.
Brainreader Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 28, 2025 | ||||
| Seed | Oct 30, 2019 |
Brainreader Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CBC Investment Group | Seed |
| Dahlgren Capital | Series A |
| Investo Capital | Seed, Series A |
| Bevica Innovation A/S | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 165% MoM, reaching 6.2K.
Brainreader Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Brainreader's valuation, stock price, and market status.